Clinical Trials


MBPCC-PS 08-03
 
Cancer Type: Melanoma
Description: A Randomized, Double-Blind, Phase 3 Trial of STA-4783 in Combination with Paclitaxel versus Paclitaxel Alone for Treatment of Chemotherapy-Na?ve Subjects with Stage IV Metastatic Melanoma (SYMMETRY)
Entity Approving The Trial:
  Industry Sponsored
Phase: III
Site-Wide Accrual Goal: 630
 
Related Files
No related files found.
 
Related Links
No related links found.